Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ACE2,Angiotensin-converting enzyme 2,24220,1857,1.29 [1.20-1.40],5.282466417903734e-11
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,24483,1862,1.58 [1.34-1.87],7.775231331712845e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21415,1614,1.42 [1.22-1.65],6.304665384450642e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24754,1888,0.81 [0.74-0.89],6.9741918511291525e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,21525,1620,1.37 [1.19-1.59],2.0438337613810287e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ADM,Pro-adrenomedullin,24887,1888,1.67 [1.43-1.95],1.495001586762739e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AGR2,Anterior gradient protein 2 homolog,23887,1814,1.12 [1.07-1.16],6.090648305644509e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AGRN,Agrin,24793,1889,1.29 [1.15-1.46],3.27010211182747e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ALPP,"Alkaline phosphatase, placental type",24579,1861,1.08 [1.04-1.13],4.121228252842936e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AMBP,Protein AMBP,24852,1886,1.91 [1.56-2.34],5.424836810488819e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ANGPT2,Angiopoietin-2,24887,1888,1.31 [1.18-1.45],4.857191635990234e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ANXA10,Annexin A10,24088,1828,1.12 [1.06-1.17],6.1372247623928455e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AREG,Amphiregulin,24579,1861,1.23 [1.14-1.33],2.767159713953939e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,24521,1863,1.62 [1.41-1.85],3.069967853423157e-12
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,21552,1627,1.52 [1.28-1.81],2.810401425675288e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",24793,1889,1.37 [1.18-1.59],2.9317558717177064e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",BMPER,BMP-binding endothelial regulator protein,21072,1600,1.52 [1.24-1.86],4.888479216515305e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",BRK1,Protein BRICK1,24088,1828,1.21 [1.10-1.33],6.620741884100752e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",BST2,Bone marrow stromal antigen 2,24895,1890,1.15 [1.07-1.24],9.840692884963428e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,24621,1874,1.36 [1.22-1.50],4.559451527778994e-09
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CA14,Carbonic anhydrase 14,24887,1888,0.74 [0.66-0.84],1.072968801611497e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CA6,Carbonic anhydrase 6,24597,1874,0.87 [0.81-0.93],1.4951274118405447e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CALCA,Calcitonin,24473,1862,1.15 [1.07-1.24],8.960450252693858e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CBLN4,Cerebellin-4,24887,1888,0.74 [0.65-0.84],3.0723515426022567e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20989,1585,1.21 [1.13-1.31],5.766868898553538e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CCL16,C-C motif chemokine 16,24974,1905,1.20 [1.10-1.29],9.46543131428229e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CCN1,CCN family member 1,24535,1859,1.12 [1.06-1.18],2.5296850273806024e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD274,Programmed cell death 1 ligand 1,24521,1863,1.29 [1.16-1.45],6.528337914794949e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD302,CD302 antigen,24579,1861,1.43 [1.25-1.64],1.273324346721164e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD4,T-cell surface glycoprotein CD4,24586,1872,1.28 [1.15-1.44],1.3215976211367603e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD83,CD83 antigen,24621,1874,1.30 [1.15-1.46],2.1612797702682188e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CDCP1,CUB domain-containing protein 1,24521,1863,1.24 [1.14-1.35],1.6617669858403068e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23771,1799,1.23 [1.15-1.31],6.706720856518806e-11
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21525,1620,1.26 [1.12-1.42],7.770923786292196e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,21525,1620,0.85 [0.78-0.92],6.651802519251266e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CHAD,Chondroadherin,21072,1600,0.84 [0.77-0.92],9.44350161887646e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21483,1617,1.35 [1.21-1.52],2.746627713595642e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CHGA,Chromogranin-A,21525,1620,1.16 [1.11-1.22],3.2547650656571584e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CHI3L1,Chitinase-3-like protein 1,24104,1844,1.15 [1.09-1.21],2.641322134634064e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,24808,1895,1.44 [1.24-1.67],1.5699695394109354e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CNTN1,Contactin-1,24974,1905,0.70 [0.60-0.80],1.170444800207644e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CNTN5,Contactin-5,24736,1883,0.76 [0.68-0.85],9.060635927394868e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,24772,1894,1.55 [1.30-1.85],1.1099809091687674e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,24974,1905,1.29 [1.15-1.46],2.1110784478374912e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CPM,Carboxypeptidase M,24781,1884,1.40 [1.25-1.57],1.09373674282432e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20922,1582,1.40 [1.19-1.64],3.302771876589331e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,21072,1600,1.36 [1.20-1.54],1.6901955342668916e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CSTB,Cystatin-B,24324,1870,1.28 [1.17-1.41],3.160114357431081e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CTSF,Cathepsin F,24754,1888,1.24 [1.12-1.37],2.469918491577225e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CTSL,Cathepsin L1,24687,1881,1.45 [1.23-1.72],1.4719955383363388e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,24621,1874,1.27 [1.18-1.36],8.34921265893193e-11
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CXCL17,C-X-C motif chemokine 17,24924,1902,1.24 [1.13-1.36],2.749065659861004e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24754,1888,1.28 [1.14-1.44],2.474566361331296e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24579,1861,1.21 [1.10-1.32],2.7032273416223467e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,24356,1847,1.08 [1.05-1.11],4.9347574630299017e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,24887,1888,1.36 [1.21-1.52],1.7485124174554893e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21415,1614,1.40 [1.20-1.63],1.1892560605052184e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EFNA1,Ephrin-A1,24635,1879,1.48 [1.27-1.71],3.167638634649814e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EFNA4,Ephrin-A4,24483,1862,1.41 [1.23-1.61],1.2111382925906148e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EGFR,Epidermal growth factor receptor,24974,1905,0.45 [0.35-0.58],2.8928476275197847e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ELN,Elastin,21533,1627,1.44 [1.27-1.65],4.034782911542447e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EPHA2,Ephrin type-A receptor 2,23818,1792,1.32 [1.15-1.51],4.69450466219792e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EPO,Erythropoietin,24621,1874,1.11 [1.06-1.17],1.2724448534800195e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FABP3,"Fatty acid-binding protein, heart",21533,1627,1.23 [1.12-1.35],1.45993982333009e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FAP,Prolyl endopeptidase FAP,24974,1905,0.69 [0.59-0.80],1.0162561980768223e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FGF21,Fibroblast growth factor 21,24846,1883,1.07 [1.04-1.11],4.5405713779563887e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,24754,1888,1.50 [1.25-1.81],1.7398867910794213e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FOLR1,Folate receptor alpha,24635,1876,1.39 [1.21-1.61],6.842931280398686e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24579,1861,1.38 [1.19-1.59],1.4495508305249375e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GAST,Gastrin,21483,1617,1.13 [1.09-1.16],1.0585379987730822e-12
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GCG,Pro-glucagon,24081,1831,1.07 [1.03-1.10],9.202191502387144e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20572,1547,1.27 [1.17-1.38],2.6809931161937765e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GDF15,Growth/differentiation factor 15,24974,1905,1.44 [1.34-1.55],1.565281816396051e-23
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,24635,1879,1.18 [1.08-1.27],8.826030639312943e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GPR37,Prosaposin receptor GPR37,24220,1857,1.18 [1.11-1.26],1.6539903173057965e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",24579,1861,1.18 [1.11-1.26],4.2331047407648043e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GUCA2A,Guanylin,24560,1877,1.32 [1.17-1.49],8.620095958516432e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,24852,1886,1.20 [1.13-1.29],3.0180517190609583e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,24676,1882,1.32 [1.17-1.49],3.592477346577287e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,21483,1617,1.13 [1.06-1.21],9.264831905829016e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21483,1617,1.20 [1.11-1.29],2.1901555009983373e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20889,1580,1.42 [1.26-1.59],4.8322940742752696e-09
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,24347,1856,1.46 [1.33-1.60],1.5150616285621213e-15
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24687,1881,1.30 [1.15-1.46],1.695761522665855e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,24687,1881,1.33 [1.16-1.51],3.390974811419245e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,24793,1889,1.34 [1.17-1.54],3.262246026584769e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IL15,Interleukin-15,24621,1874,1.42 [1.26-1.60],9.535254792740522e-09
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,24621,1874,1.36 [1.22-1.52],3.223252683173888e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IMMT,MICOS complex subunit MIC60,21411,1615,1.26 [1.14-1.38],1.967540616911212e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGA11,Integrin alpha-11,24621,1874,0.78 [0.69-0.88],4.3106401622391855e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGAM,Integrin alpha-M,24676,1882,0.68 [0.59-0.77],5.812172715009193e-09
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGAV,Integrin alpha-V,24887,1888,0.56 [0.44-0.72],4.580676756687759e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGB2,Integrin beta-2,24511,1880,0.65 [0.57-0.76],1.7694083430877057e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,24707,1884,0.76 [0.66-0.87],6.393838806754112e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",KITLG,Kit ligand,24687,1881,0.80 [0.72-0.89],5.767331278814504e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24677,1880,1.24 [1.12-1.37],3.524249746653881e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,24886,1902,1.22 [1.13-1.32],2.605974712998038e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LAYN,Layilin,24473,1862,1.36 [1.21-1.54],3.54632793462998e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LGALS1,Galectin-1,24687,1881,1.28 [1.14-1.44],5.065374755175093e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LGALS3,Galectin-3,24734,1885,1.43 [1.25-1.63],2.7321075177966293e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LGALS4,Galectin-4,24677,1880,1.27 [1.18-1.37],2.3606406842663924e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LGALS9,Galectin-9,24672,1880,1.46 [1.29-1.65],1.961239575094876e-09
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24192,1848,1.26 [1.14-1.38],1.904916300498492e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LMNB2,Lamin-B2,21483,1617,1.42 [1.21-1.68],3.1746391454174086e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,24192,1848,0.75 [0.67-0.83],9.790129520373305e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24433,1860,1.16 [1.08-1.25],7.198305587779091e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MERTK,Tyrosine-protein kinase Mer,24924,1902,1.54 [1.32-1.79],5.57111041230875e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MMP7,Matrilysin,24176,1851,1.20 [1.10-1.31],6.507331900812783e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MSLN,Mesothelin,24542,1857,1.18 [1.10-1.27],5.2629816815333735e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MVK,Mevalonate kinase,24192,1848,1.11 [1.06-1.17],6.799650211619085e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NCAM1,Neural cell adhesion molecule 1,24750,1889,0.70 [0.61-0.82],2.771256438256957e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21415,1614,1.48 [1.28-1.70],5.4266701106863615e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NCS1,Neuronal calcium sensor 1,24887,1888,1.46 [1.27-1.69],1.667977139786337e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NECTIN2,Nectin-2,24647,1878,1.55 [1.35-1.78],4.5162129505420284e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NEFL,Neurofilament light polypeptide,24009,1824,1.23 [1.11-1.36],4.0075258847021486e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,21167,1596,1.39 [1.21-1.59],2.9707332785368694e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,24687,1881,1.37 [1.21-1.56],1.5221614363847934e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NPL,N-acetylneuraminate lyase,21533,1627,1.27 [1.14-1.41],6.311411262057308e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,21483,1617,1.32 [1.16-1.49],1.930864014070936e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NTRK3,NT-3 growth factor receptor,24895,1890,0.67 [0.55-0.80],1.5240810812336408e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24687,1881,1.11 [1.07-1.16],3.6125285186141604e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NUCB2,Nucleobindin-2,24847,1883,1.26 [1.13-1.40],2.6549241898596344e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",OCLN,Occludin,21504,1625,1.46 [1.32-1.62],2.1863031717343397e-13
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",OMD,Osteomodulin,24793,1889,0.82 [0.75-0.89],5.181885420730452e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PALM2,Paralemmin-2,21483,1617,1.39 [1.23-1.56],1.129226076401869e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PGA4,Pepsin A-4,21552,1627,1.20 [1.12-1.29],1.2866831003232628e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24521,1863,1.45 [1.26-1.68],3.225391765211785e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PIGR,Polymeric immunoglobulin receptor,24358,1854,1.50 [1.34-1.67],7.508835481794863e-13
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24676,1882,1.37 [1.17-1.59],6.905550640262163e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24676,1882,1.22 [1.11-1.35],6.825035599167099e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PLA2G15,Phospholipase A2 group XV,24754,1888,1.41 [1.21-1.65],1.449354980005746e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,24517,1866,1.82 [1.57-2.11],3.336536330528364e-15
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PLIN3,Perilipin-3,24687,1881,1.20 [1.10-1.32],7.556472875014409e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PRAP1,Proline-rich acidic protein 1,21525,1620,1.28 [1.15-1.44],1.818167099646213e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PRSS8,Prostasin,24588,1873,1.36 [1.23-1.49],1.0465302886890343e-09
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,24974,1905,0.75 [0.65-0.86],5.044426202049744e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,24974,1905,0.70 [0.59-0.82],2.031926929563666e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PVR,Poliovirus receptor,24895,1890,1.32 [1.19-1.46],2.649836002871493e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,24794,1893,1.25 [1.15-1.36],6.839582397492238e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,21504,1625,1.40 [1.25-1.56],1.364938723848114e-09
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",REN,Renin,24687,1881,1.15 [1.09-1.21],2.617634139104044e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RNASE1,Ribonuclease pancreatic,21552,1627,1.47 [1.24-1.74],9.221065578102858e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RNASE6,Ribonuclease K6,21391,1612,1.38 [1.20-1.58],4.62542297611239e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,20989,1585,1.45 [1.24-1.70],3.089629216256071e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SCARB2,Lysosome membrane protein 2,24067,1831,1.53 [1.34-1.74],2.8991470295015463e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,20905,1581,1.21 [1.10-1.33],8.249881224833407e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SELENOP,Selenoprotein P,21577,1632,0.65 [0.52-0.81],9.14646888550404e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SEPTIN8,Septin-8,21444,1615,1.39 [1.22-1.59],1.2284515449735743e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SERPINH1,Serpin H1,21111,1598,1.08 [1.04-1.12],5.599918568676873e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SHISA5,Protein shisa-5,21525,1620,1.46 [1.23-1.73],1.5057570816262925e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SIGLEC1,Sialoadhesin,24793,1889,1.23 [1.12-1.35],2.271468356647773e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,24776,1883,1.22 [1.13-1.33],2.2905203612344075e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,24081,1831,1.32 [1.18-1.49],1.974058899932629e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,24676,1882,1.27 [1.16-1.39],1.1773532785810573e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TCTN3,Tectonic-3,21533,1627,1.39 [1.18-1.64],6.809698001344093e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TFF1,Trefoil factor 1,24550,1873,1.12 [1.07-1.18],4.995820072772892e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TFF2,Trefoil factor 2,24751,1887,1.18 [1.10-1.26],4.026742938233361e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TFF3,Trefoil factor 3,24630,1881,1.24 [1.16-1.32],3.853940484506471e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TGFA,Protransforming growth factor alpha,24621,1874,1.22 [1.12-1.33],2.2446897881789337e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,24886,1902,1.24 [1.12-1.37],6.032752750378334e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TGFBR2,TGF-beta receptor type-2,24754,1888,1.38 [1.22-1.57],3.959498429429821e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNF,Tumor necrosis factor,24183,1853,1.21 [1.11-1.32],2.8190567787743755e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24521,1863,1.48 [1.32-1.66],2.151965877579732e-11
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24521,1863,1.26 [1.18-1.34],7.199338570910531e-12
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24924,1902,1.30 [1.17-1.45],6.877902428525551e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24754,1888,1.45 [1.29-1.62],2.76222881250227e-10
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24721,1883,1.45 [1.27-1.66],4.9400326522877975e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24676,1882,1.46 [1.27-1.68],1.158859620849438e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24676,1882,1.29 [1.18-1.42],3.1996610683135764e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24621,1874,0.87 [0.81-0.93],3.194706741106928e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24793,1889,1.42 [1.22-1.65],6.964599431808181e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,24677,1880,1.22 [1.12-1.32],1.127000965596746e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TSHB,Thyrotropin subunit beta,24687,1881,0.90 [0.85-0.94],5.21171937820838e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",UMOD,Uromodulin,24906,1904,0.84 [0.78-0.90],2.8021602117603724e-06
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",VEGFA,Vascular endothelial growth factor A,24839,1893,1.14 [1.07-1.22],9.993233832423136e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,21411,1615,1.35 [1.25-1.46],3.0541621717297104e-15
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,24644,1878,1.34 [1.21-1.49],2.170521442421376e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,23412,1788,1.52 [1.37-1.69],2.916735039293804e-15
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24448,1860,0.75 [0.68-0.83],2.6891941452535092e-08
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",YAP1,Transcriptional coactivator YAP1,21483,1617,1.45 [1.22-1.73],2.307690960735737e-05
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,24220,1857,1.22 [1.12-1.33],1.0682435342995525e-05
